Lisdexamfetamine, marketed as Vyvanse, is a controlled medication indicated for attention deficit hyperactivity disorder in children and adults . In Canada, its distribution is overseen by Health Canada. This overview intends to offer understandable information on its uses , possible risks, appro… Read More